{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:18:58Z","timestamp":1788308338401,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76293-x","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:36:53Z","timestamp":1785821813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Soaad","family":"Galal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Chaltel Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9o","family":"Moury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiou","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-1409","authenticated-orcid":false,"given":"Jean-Jacques","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"76293_CR1","first-page":"52","volume":"64","author":"C DeSantis","year":"2014","unstructured":"DeSantis, C., Ma, J., Bryan, L. & Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 64, 52\u201362 (2014).","journal-title":"CA Cancer J. Clin."},{"key":"76293_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"76293_CR3","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res 13, 4429\u20134434 (2007).","journal-title":"Clin. Cancer Res"},{"key":"76293_CR4","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","volume":"20","author":"O Gluz","year":"2009","unstructured":"Gluz, O. et al. Triple-negative breast cancer-current status and future directions. Ann. Oncol. 20, 1913\u20131927 (2009).","journal-title":"Ann. Oncol."},{"key":"76293_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. N. Engl. J. Med. 363, 1938\u20131948 (2010).","journal-title":"N. Engl. J. Med."},{"key":"76293_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"76293_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha, E. A. Prognostic markers in triple-negative breast cancer. Cancer 109, 25\u201332 (2007).","journal-title":"Cancer"},{"key":"76293_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-008-0086-2","volume":"115","author":"R Dent","year":"2009","unstructured":"Dent, R. et al. Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res. Treat. 115, 423\u2013428 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"76293_CR9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","volume":"8","author":"S Al-Mahmood","year":"2018","unstructured":"Al-Mahmood, S., Sapiezynski, J., Garbuzenko, O. B. & Minko, T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv. Transl. Res 8, 1483\u20131507 (2018).","journal-title":"Drug Deliv. Transl. Res"},{"key":"76293_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006).","journal-title":"Cell"},{"key":"76293_CR11","doi-asserted-by":"publisher","unstructured":"Medeiros, B. & Allan, A. L. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20092272 (2019).","DOI":"10.3390\/ijms20092272"},{"key":"76293_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563\u2013572 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"76293_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/labinvest.2017.104","volume":"98","author":"I Khan","year":"2018","unstructured":"Khan, I. & Steeg, P. S. Metastasis suppressors: functional pathways. Lab Invest 98, 198\u2013210 (2018).","journal-title":"Lab Invest"},{"key":"76293_CR14","doi-asserted-by":"publisher","first-page":"32389","DOI":"10.1074\/jbc.M203115200","volume":"277","author":"MT Hartsough","year":"2002","unstructured":"Hartsough, M. T. et al. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J. Biol. Chem. 277, 32389\u201332399 (2002).","journal-title":"J. Biol. Chem."},{"key":"76293_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1158\/0008-5472.713.65.3","volume":"65","author":"DB DeWald","year":"2005","unstructured":"DeWald, D. B. et al. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res. 65, 713\u2013717 (2005).","journal-title":"Cancer Res."},{"key":"76293_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6406","volume":"5","author":"C Gong","year":"2014","unstructured":"Gong, C. et al. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. Nat. Commun. 5, 5406 (2014).","journal-title":"Nat. Commun."},{"key":"76293_CR17","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1158\/0008-5472.CAN-04-3043","volume":"65","author":"S Goodison","year":"2005","unstructured":"Goodison, S. et al. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 65, 6042\u20136053 (2005).","journal-title":"Cancer Res."},{"key":"76293_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/0008-5472.CAN-08-3559","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst, D. R. et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69, 1279\u20131283 (2009).","journal-title":"Cancer Res."},{"key":"76293_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1073\/pnas.1514663113","volume":"113","author":"S Ozturk","year":"2016","unstructured":"Ozturk, S. et al. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc. Natl. Acad. Sci. USA 113, 638\u2013643 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76293_CR20","doi-asserted-by":"publisher","first-page":"1189350","DOI":"10.3389\/fonc.2023.1189350","volume":"13","author":"TH Lai","year":"2023","unstructured":"Lai, T. H. et al. Manipulating RKIP reverses the metastatic potential of breast cancer cells. Front Oncol. 13, 1189350 (2023).","journal-title":"Front Oncol."},{"key":"76293_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep30934","volume":"6","author":"VM Lopez-Ozuna","year":"2016","unstructured":"Lopez-Ozuna, V. M., Hachim, I. Y., Hachim, M. Y., Lebrun, J. J. & Ali, S. Prolactin pro-differentiation pathway in triple negative breast cancer: impact on prognosis and potential therapy. Sci. Rep. 6, 30934 (2016).","journal-title":"Sci. Rep."},{"key":"76293_CR22","doi-asserted-by":"publisher","first-page":"993570","DOI":"10.3389\/fendo.2022.993570","volume":"13","author":"S Ali","year":"2022","unstructured":"Ali, S., Hamam, D., Liu, X. & Lebrun, J. J. Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer. Front Endocrinol. 13, 993570 (2022).","journal-title":"Front Endocrinol."},{"key":"76293_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.scr.2015.08.001","volume":"15","author":"F Liu","year":"2015","unstructured":"Liu, F. et al. Prolactin\/Jak2 directs apical\/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1\/2 pathway. Stem Cell Res. 15, 376\u2013383 (2015).","journal-title":"Stem Cell Res."},{"key":"76293_CR24","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1158\/0008-5472.CAN-05-2292","volume":"66","author":"Z Nouhi","year":"2006","unstructured":"Nouhi, Z. et al. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res 66, 1824\u20131832 (2006).","journal-title":"Cancer Res"},{"key":"76293_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/BD-2010-0307","volume":"32","author":"KJ Chavez","year":"2010","unstructured":"Chavez, K. J., Garimella, S. V. & Lipkowitz, S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis. 32, 35\u201348 (2010).","journal-title":"Breast Dis."},{"key":"76293_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10549-009-0460-8","volume":"121","author":"A Hollestelle","year":"2010","unstructured":"Hollestelle, A. et al. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res. Treat. 121, 53\u201364 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"76293_CR27","doi-asserted-by":"publisher","unstructured":"Lehmann, B. D. et al. PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors. Breast Cancer Res. 16, https:\/\/doi.org\/10.1186\/s13058-014-0406-x (2014).","DOI":"10.1186\/s13058-014-0406-x"},{"key":"76293_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395\u2013399 (2012).","journal-title":"Nature"},{"key":"76293_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23316-4","volume":"12","author":"M Dai","year":"2021","unstructured":"Dai, M. et al. In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR\/Hippo targeted combination therapy. Nat. Commun. 12, 3055 (2021).","journal-title":"Nat. Commun."},{"key":"76293_CR30","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/0008-5472.CAN-20-2121","volume":"81","author":"M Dai","year":"2021","unstructured":"Dai, M. et al. Differential regulation of cancer progression by CDK4\/6 plays a central role in DNA replication and repair pathways. Cancer Res. 81, 1332\u20131346 (2021).","journal-title":"Cancer Res."},{"key":"76293_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-023-00497-9","volume":"12","author":"G Yan","year":"2023","unstructured":"Yan, G. et al. Combined in vitro\/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance. Oncogenesis 12, 51 (2023).","journal-title":"Oncogenesis"},{"key":"76293_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02029-4","volume":"23","author":"S Poulet","year":"2024","unstructured":"Poulet, S. et al. Genome-wide in vivo CRISPR screen identifies TGFbeta3 as actionable biomarker of palbociclib resistance in triple negative breast cancer. Mol. Cancer 23, 118 (2024).","journal-title":"Mol. Cancer"},{"key":"76293_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cell.2015.11.062","volume":"164","author":"R Marcotte","year":"2016","unstructured":"Marcotte, R. et al. Functional genomic landscape of human breast cancer drivers, vulnerabilities, and resistance. Cell 164, 293\u2013309 (2016).","journal-title":"Cell"},{"key":"76293_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","volume":"10","author":"RM Neve","year":"2006","unstructured":"Neve, R. M. et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10, 515\u2013527 (2006).","journal-title":"Cancer Cell"},{"key":"76293_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"76293_CR36","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779\u20131784 (2017).","journal-title":"Nat. Genet."},{"key":"76293_CR37","doi-asserted-by":"publisher","unstructured":"Boudreault, J. et al. Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma. Mol. Cancer 25, https:\/\/doi.org\/10.1186\/s12943-026-02587-9 (2026).","DOI":"10.1186\/s12943-026-02587-9"},{"key":"76293_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"76293_CR39","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1038\/s41388-019-0698-5","volume":"38","author":"XL Zhou","year":"2019","unstructured":"Zhou, X. L., Zhu, C. Y., Wu, Z. G., Guo, X. & Zou, W. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis. Oncogene 38, 4028\u20134046 (2019).","journal-title":"Oncogene"},{"key":"76293_CR40","doi-asserted-by":"publisher","first-page":"114507","DOI":"10.1016\/j.celrep.2024.114507","volume":"43","author":"B Han","year":"2024","unstructured":"Han, B. et al. Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer. Cell Rep. 43, 114507 (2024).","journal-title":"Cell Rep."},{"key":"76293_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4048\/jbc.2023.26.e42","volume":"26","author":"YS Lee","year":"2023","unstructured":"Lee, Y. S., Kang, J., Jung, E. S. & Lee, A. High expression of NRF2 and low expression of KEAP1 predict worse survival in patients with operable triple-negative breast cancer. J. Breast Cancer 26, 461\u2013478 (2023).","journal-title":"J. Breast Cancer"},{"key":"76293_CR42","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1158\/1078-0432.CCR-14-1887","volume":"21","author":"JM Hartikainen","year":"2015","unstructured":"Hartikainen, J. M. et al. KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes. Clin. Cancer Res 21, 1591\u20131601 (2015).","journal-title":"Clin. Cancer Res"},{"key":"76293_CR43","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1101\/gad.304261.117","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase. Genes Dev. 31, 1939\u20131957 (2017).","journal-title":"Genes Dev."},{"key":"76293_CR44","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2016.04.076","volume":"15","author":"S Manteghi","year":"2016","unstructured":"Manteghi, S. et al. Haploinsufficiency of the ESCRT Component HD-PTP Predisposes to Cancer. Cell Rep. 15, 1893\u20131900 (2016).","journal-title":"Cell Rep."},{"key":"76293_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.27","volume":"4","author":"LV Rhodes","year":"2015","unstructured":"Rhodes, L. V. et al. Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1. Oncogenesis 4, e168 (2015).","journal-title":"Oncogenesis"},{"key":"76293_CR46","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1021\/pr500119a","volume":"13","author":"D Subramonian","year":"2014","unstructured":"Subramonian, D. et al. Analysis of changes in SUMO-2\/3 modification during breast cancer progression and metastasis. J. Proteome Res. 13, 3905\u20133918 (2014).","journal-title":"J. Proteome Res."},{"key":"76293_CR47","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1080\/15384101.2020.1859196","volume":"19","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle 19, 3622\u20133631 (2020).","journal-title":"Cell Cycle"},{"key":"76293_CR48","doi-asserted-by":"publisher","first-page":"550469","DOI":"10.3389\/fphar.2020.550469","volume":"11","author":"P Yu","year":"2020","unstructured":"Yu, P. et al. PKM2-c-Myc-survivin cascade regulates the cell proliferation, migration, and tamoxifen resistance in breast cancer. Front Pharm. 11, 550469 (2020).","journal-title":"Front Pharm."},{"key":"76293_CR49","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Binding blockade between TLN1 and integrin beta1 represses triple-negative breast cancer. Elife 11, https:\/\/doi.org\/10.7554\/eLife.68481 (2022).","DOI":"10.7554\/eLife.68481"},{"key":"76293_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1083\/jcb.201312046","volume":"205","author":"BT Beaty","year":"2014","unstructured":"Beaty, B. T. et al. Talin regulates moesin-NHE-1 recruitment to invadopodia and promotes mammary tumor metastasis. J. Cell Biol. 205, 737\u2013751 (2014).","journal-title":"J. Cell Biol."},{"key":"76293_CR51","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan, F. M. et al. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 568, 511\u2013516 (2019).","journal-title":"Nature"},{"key":"76293_CR52","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"76293_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 14, 128 (2013).","journal-title":"BMC Bioinforma."},{"key":"76293_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-0220-5","volume":"9","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187. Oncogenesis 9, 36 (2020).","journal-title":"Oncogenesis"},{"key":"76293_CR55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.semcdb.2014.09.008","volume":"36","author":"TA Martin","year":"2014","unstructured":"Martin, T. A. The role of tight junctions in cancer metastasis. Semin Cell Dev. Biol. 36, 224\u2013231 (2014).","journal-title":"Semin Cell Dev. Biol."},{"key":"76293_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41416-020-01179-8","volume":"124","author":"I Khan","year":"2021","unstructured":"Khan, I. & Steeg, P. S. Endocytosis: a pivotal pathway for regulating metastasis. Br. J. Cancer 124, 66\u201375 (2021).","journal-title":"Br. J. Cancer"},{"key":"76293_CR57","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7150\/ijbs.6.784","volume":"6","author":"J Luo","year":"2010","unstructured":"Luo, J., Li, Y. N., Wang, F., Zhang, W. M. & Geng, X. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. Int J. Biol. Sci. 6, 784\u2013795 (2010).","journal-title":"Int J. Biol. Sci."},{"key":"76293_CR58","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.18632\/oncotarget.23704","volume":"9","author":"N Mahmood","year":"2018","unstructured":"Mahmood, N. Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications. Oncotarget 9, 5169\u20135183 (2018).","journal-title":"Oncotarget"},{"key":"76293_CR59","doi-asserted-by":"publisher","unstructured":"Coppola, A. et al. S-Adenosylmethionine inhibits cell growth and migration of triple negative breast cancer cells through upregulating MiRNA-34c and MiRNA-449a. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22010286 (2020).","DOI":"10.3390\/ijms22010286"},{"key":"76293_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-007-9732-3","volume":"110","author":"AD Richardson","year":"2008","unstructured":"Richardson, A. D., Yang, C., Osterman, A. & Smith, J. W. Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res. Treat. 110, 297\u2013307 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"76293_CR61","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/1541-7786.MCR-19-0606","volume":"18","author":"AM Li","year":"2020","unstructured":"Li, A. M. et al. Metabolic profiling reveals a dependency of human metastatic breast cancer on mitochondrial serine and one-carbon unit metabolism. Mol. Cancer Res 18, 599\u2013611 (2020).","journal-title":"Mol. Cancer Res"},{"key":"76293_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"76293_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327 (2022).","journal-title":"Neoplasia"},{"key":"76293_CR64","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1021\/pr501254j","volume":"14","author":"NJ Edwards","year":"2015","unstructured":"Edwards, N. J. et al. The CPTAC data portal: a resource for cancer proteomics research. J. Proteome Res 14, 2707\u20132713 (2015).","journal-title":"J. Proteome Res"},{"key":"76293_CR65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658 (2017).","journal-title":"Neoplasia"},{"key":"76293_CR66","doi-asserted-by":"publisher","first-page":"859113","DOI":"10.3389\/fpubh.2022.859113","volume":"10","author":"R Tan","year":"2022","unstructured":"Tan, R. et al. Assessing real-world racial differences among patients with metastatic triple-negative breast cancer in US community practices. Front. Public Health 10, 859113 (2022).","journal-title":"Front. Public Health"},{"key":"76293_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"76293_CR68","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).","journal-title":"Sci. Signal"},{"key":"76293_CR69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson, D. R. et al. Integrative clinical genomics of metastatic cancer. Nature 548, 297\u2013303 (2017).","journal-title":"Nature"},{"key":"76293_CR70","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1038\/sj.onc.1206757","volume":"22","author":"T Bogenrieder","year":"2003","unstructured":"Bogenrieder, T. & Herlyn, M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22, 6524\u20136536 (2003).","journal-title":"Oncogene"},{"key":"76293_CR71","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ncponc0905","volume":"4","author":"S Banerjee","year":"2007","unstructured":"Banerjee, S., Dowsett, M., Ashworth, A. & Martin, L. A. Mechanisms of disease: angiogenesis and the management of breast cancer. Nat. Clin. Pr. Oncol. 4, 536\u2013550 (2007).","journal-title":"Nat. Clin. Pr. Oncol."},{"key":"76293_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3322","volume":"14","author":"M Dai","year":"2012","unstructured":"Dai, M. et al. A novel function for p21Cip1 and acetyltransferase p\/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion. Breast Cancer Res. 14, R127 (2012).","journal-title":"Breast Cancer Res."},{"key":"76293_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3441","volume":"15","author":"M Dai","year":"2013","unstructured":"Dai, M. et al. Cyclin D1 cooperates with p21 to regulate TGFbeta-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 15, R49 (2013).","journal-title":"Breast Cancer Res."},{"key":"76293_CR74","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1134\/S0006297919070071","volume":"84","author":"MV Zavyalova","year":"2019","unstructured":"Zavyalova, M. V. et al. Intravasation as a key step in cancer metastasis. Biochem. (Mosc. 84, 762\u2013772 (2019).","journal-title":"Biochem. (Mosc."},{"key":"76293_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massague","year":"2016","unstructured":"Massague, J. & Obenauf, A. C. Metastatic colonization by circulating tumour cells. Nature 529, 298\u2013306 (2016).","journal-title":"Nature"},{"key":"76293_CR76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583\u2013588 (2015).","journal-title":"Nature"},{"key":"76293_CR77","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/jnci\/36.4.641","volume":"36","author":"H Wexler","year":"1966","unstructured":"Wexler, H. Accurate identification of experimental pulmonary metastases. J. Nat. Cancer Inst. 36, 641\u2013645 (1966).","journal-title":"J. Nat. Cancer Inst."},{"key":"76293_CR78","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","volume":"17","author":"D Lallemand","year":"2003","unstructured":"Lallemand, D., Curto, M., Saotome, I., Giovannini, M. & McClatchey, A. I. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 17, 1090\u20131100 (2003).","journal-title":"Genes Dev."},{"key":"76293_CR79","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260 (2015).","journal-title":"Cell"},{"key":"76293_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau, G. A. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363, 515\u2013521 (1993).","journal-title":"Nature"},{"key":"76293_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02898-w","volume":"24","author":"NK Tuano","year":"2023","unstructured":"Tuano, N. K. et al. CRISPR screens identify gene targets at breast cancer risk loci. Genome Biol. 24, 59 (2023).","journal-title":"Genome Biol."},{"key":"76293_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50794-w","volume":"9","author":"K Yamanoi","year":"2019","unstructured":"Yamanoi, K. et al. Acquisition of a side population fraction augments malignant phenotype in ovarian cancer. Sci. Rep. 9, 14215 (2019).","journal-title":"Sci. Rep."},{"key":"76293_CR83","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","volume":"102","author":"L Hu","year":"2010","unstructured":"Hu, L., McArthur, C. & Jaffe, R. B. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br. J. Cancer 102, 1276\u20131283 (2010).","journal-title":"Br. J. Cancer"},{"key":"76293_CR84","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax, C. et al. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101, 14228\u201314233 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76293_CR85","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1091\/mbc.e08-07-0716","volume":"19","author":"HA Morrison","year":"2008","unstructured":"Morrison, H. A. et al. Regulation of early endosomal entry by the Drosophila tumor suppressors Rabenosyn and Vps45. Mol. Biol. Cell 19, 4167\u20134176 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"76293_CR86","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/gcc.20569","volume":"47","author":"SH Nordgard","year":"2008","unstructured":"Nordgard, S. H. et al. Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 47, 680\u2013696 (2008).","journal-title":"Genes Chromosomes Cancer"},{"key":"76293_CR87","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/(SICI)1098-2264(199707)19:3<185::AID-GCC8>3.0.CO;2-U","volume":"19","author":"K Driouch","year":"1997","unstructured":"Driouch, K. et al. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer 19, 185\u2013191 (1997).","journal-title":"Genes Chromosomes Cancer"},{"key":"76293_CR88","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/bjc.1997.43","volume":"75","author":"A Iida","year":"1997","unstructured":"Iida, A. et al. Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. Br. J. Cancer 75, 264\u2013267 (1997).","journal-title":"Br. J. Cancer"},{"key":"76293_CR89","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05668-z","volume":"614","author":"V Despic","year":"2023","unstructured":"Despic, V. & Jaffrey, S. R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature 614, 358\u2013366 (2023).","journal-title":"Nature"},{"key":"76293_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64821-0","volume":"16","author":"S Nukaga","year":"2025","unstructured":"Nukaga, S. et al. Mutation of CMTR2 in lung adenocarcinoma alters RNA alternative splicing and reveals therapeutic vulnerabilities. Nat. Commun. 16, 9754 (2025).","journal-title":"Nat. Commun."},{"key":"76293_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ydbio.2024.07.019","volume":"516","author":"AV Yermalovich","year":"2024","unstructured":"Yermalovich, A. V. et al. An essential role for Cmtr2 in mammalian embryonic development. Dev. Biol. 516, 47\u201358 (2024).","journal-title":"Dev. Biol."},{"key":"76293_CR92","doi-asserted-by":"publisher","unstructured":"Ghanbarian, H., Aghamiri, S., Eftekhary, M., Wagner, N. & Wagner, K. D. Small activating RNAs: towards the development of new therapeutic agents and clinical treatments. Cells 10, https:\/\/doi.org\/10.3390\/cells10030591 (2021).","DOI":"10.3390\/cells10030591"},{"key":"76293_CR93","doi-asserted-by":"publisher","unstructured":"Tan, C. P., Sinigaglia, L., Gomez, V., Nicholls, J. & Habib, N. A. RNA activation-a novel approach to therapeutically upregulate gene transcription. Molecules 26, https:\/\/doi.org\/10.3390\/molecules26216530 (2021).","DOI":"10.3390\/molecules26216530"},{"key":"76293_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54706-z","volume":"15","author":"MX Li","year":"2024","unstructured":"Li, M. X. et al. Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice. Nat. Commun. 15, 10539 (2024).","journal-title":"Nat. Commun."},{"key":"76293_CR95","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"76293_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015).","journal-title":"Genome Biol."},{"key":"76293_CR97","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"76293_CR98","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76293-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76293-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:03:01Z","timestamp":1788307381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76293-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76293"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76293-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9371"}}